Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-24 @ 6:40 PM
NCT ID:
NCT00772057
Eligibility Criteria:
Inclusion Criteria:
* A clinical, radiological or histologic diagnosis of cirrhosis was made
* Age was between 18 and 70 years
* Esophageal varices were small (i.e. ≤5 mm or of grade 1 or 2 according to Conn et al).
Exclusion Criteria:
* Presence of previous variceal bleeding
* Previous medical, surgical or endoscopic treatment for portal hypertension
* Child-Pugh score \>13
* Neoplastic disease of any site
* Splenic or portal vein thrombosis
* Concurrent illnesses expected to decrease life expectancy to less than one year
* Pregnancy
* Contraindication to beta-blockers (atrioventricular block, sinus bradycardia with heart rate \<50 beats per minute, arterial hypotension with systolic blood pressure \<90 mm Hg, heart failure, asthma, peripheral arterial disease, or diabetes needing insulin treatment)
* Concurrent anti-viral treatment during the study period
* Inability to perform follow-up
* Failure to give consent to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
80 Years
Study:
NCT00772057
Study Brief:
Protocol Section:
NCT00772057